Lista de obras -

'Integrative Physiology 2.0': integration of systems biology into physiology and its application to cardiovascular homeostasis.

scientific article published on 04 January 2011

A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction

artículo científico publicado en 2015

A sensitive and specific quantitation method for determination of serum cardiac myosin binding protein-C by electrochemiluminescence immunoassay.

artículo científico publicado en 2013

ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease.

artículo científico publicado en 2015

Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy

scientific article published on 01 December 2019

Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart

artículo científico publicado en 2022

Cardiac myosin binding protein C phosphorylation in cardiac disease.

artículo científico publicado en 2011

Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships

artículo científico publicado en 2013

End-diastolic force pre-activates cardiomyocytes and determines contractile force: role of titin and calcium

scientific article published on 30 July 2019

GSK3β phosphorylates newly identified site in the proline-alanine-rich region of cardiac myosin-binding protein C and alters cross-bridge cycling kinetics in human: short communication

artículo científico publicado en 2013

Gene expression profile in the diaphragm following contractile inactivity during thoracic surgery.

artículo científico publicado en 2011

Gene reprogramming in exercise-induced cardiac hypertrophy in swine: A transcriptional genomics approach.

artículo científico

Genotype-specific pathogenic effects in human dilated cardiomyopathy.

artículo científico publicado en 2017

Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction ⬇️

artículo científico publicado el 10 de junio de 2013

Left ventricular remodeling in swine after myocardial infarction: a transcriptional genomics approach.

artículo científico publicado en 2011

MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation

artículo científico publicado en 2013

MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations

artículo científico publicado en 2013

Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

artículo científico publicado en 2021

Myocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium

artículo científico publicado en 2014

Nuclear protein extraction from frozen porcine myocardium

artículo científico publicado en 2010

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart.

artículo científico publicado en 2014

Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy

artículo científico publicado en 2021

Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury.

scientific article published on 13 December 2013

Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.

artículo científico publicado en 2016

Sex Differences at the Time of Myectomy in Hypertrophic Cardiomyopathy

scientific article published on 01 June 2018

Sex-dependent pathophysiological mechanisms in hypertrophic cardiomyopathy: implications for rhythm disorders.

artículo científico publicado en 2014

Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.

artículo científico publicado en 2014

Synergistic role of ADP and Ca(2+) in diastolic myocardial stiffness ⬇️

artículo científico publicado en 2015

Thyroid Hormone-Regulated Cardiac microRNAs are Predicted to Suppress Pathological Hypertrophic Signaling.

artículo científico publicado en 2014

Uptake and remodeling of exogenous phosphatidylethanolamine in E. coli.

artículo científico publicado en 2004

Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy.

artículo científico publicado en 2018

What grows together, goes together: assessing variability in cardiomyocyte function

artículo científico publicado en 2019

Young@Heart: empowering the next generation of cardiovascular researchers

artículo científico publicado en 2020

β-adrenergic receptor signalling and its functional consequences in the diseased heart.

artículo científico publicado en 2016

Lista de obras de

'Integrative Physiology 2.0': integration of systems biology into physiology and its application to cardiovascular homeostasis.

A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction

A sensitive and specific quantitation method for determination of serum cardiac myosin binding protein-C by electrochemiluminescence immunoassay.

ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease.

Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy

Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart

Cardiac myosin binding protein C phosphorylation in cardiac disease.

Cardiac myosin-binding protein C: hypertrophic cardiomyopathy mutations and structure-function relationships

End-diastolic force pre-activates cardiomyocytes and determines contractile force: role of titin and calcium

GSK3β phosphorylates newly identified site in the proline-alanine-rich region of cardiac myosin-binding protein C and alters cross-bridge cycling kinetics in human: short communication

Gene expression profile in the diaphragm following contractile inactivity during thoracic surgery.

Gene reprogramming in exercise-induced cardiac hypertrophy in swine: A transcriptional genomics approach.

Genotype-specific pathogenic effects in human dilated cardiomyopathy.

Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction ⬇️

Left ventricular remodeling in swine after myocardial infarction: a transcriptional genomics approach.

MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation

MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations

Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

Myocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium

Nuclear protein extraction from frozen porcine myocardium

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart.

Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy

Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury.

Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.

Sex Differences at the Time of Myectomy in Hypertrophic Cardiomyopathy

Sex-dependent pathophysiological mechanisms in hypertrophic cardiomyopathy: implications for rhythm disorders.

Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.

Synergistic role of ADP and Ca(2+) in diastolic myocardial stiffness ⬇️

Thyroid Hormone-Regulated Cardiac microRNAs are Predicted to Suppress Pathological Hypertrophic Signaling.

Uptake and remodeling of exogenous phosphatidylethanolamine in E. coli.

Variable cardiac myosin binding protein-C expression in the myofilaments due to MYBPC3 mutations in hypertrophic cardiomyopathy.

What grows together, goes together: assessing variability in cardiomyocyte function

Young@Heart: empowering the next generation of cardiovascular researchers

β-adrenergic receptor signalling and its functional consequences in the diseased heart.